Sökning: "Mia Magnusson"

Hittade 3 avhandlingar innehållade orden Mia Magnusson.

  1. 1. Epigenetic regulation of gene expression in the vascular endothelium

    Författare :Mia Magnusson; Göteborgs universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; epigenetics; histone acetylation; DNA methylation; t-PA; PLAT; HUVECs; valproic acid; gene expression; enhancers;

    Sammanfattning : Epigenetic mechanisms, such as DNA methylation and histone modifications, constitute one way for a cell or an organism to respond to changes in the surrounding environment. While histone modifications are recognized to be quite dynamic, DNA methylation has been considered a more stable, or long-term, modification. LÄS MER

  3. 2. Open drug scenes and the merging of policing practice and research : a pracademic approach

    Författare :Mia-Maria Magnusson; Marie Torstensson Levander; Manne Gerell; Kim Moeller; Cynthia Lum; Malmö universitet; []
    Nyckelord :SAMHÄLLSVETENSKAP; SOCIAL SCIENCES; Policing; crime; Open drug scenes; illicit drug markets; evidence based policing; pracademic; criminology; place based criminology; translational criminology; gun violence; crime concentration; crime mapping; Kriminologi; Criminology;

    Sammanfattning : Policing research has had an upswing as the evidence-based policing movement has grown stronger and entered police practises worldwide. Within the evidence-based policing (EBP) approach, practically and academically skilled individuals, pracademics, have attracted attention as facilitating the merging of policing practice and research. LÄS MER

  4. 3. On the Prediction of Warfarin Dose

    Författare :Niclas Eriksson; Mia Wadelius; Lars Wallentin; Lars Berglund; Patrik Magnusson; Uppsala universitet; []
    Nyckelord :MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Warfarin; pharmacogenetics; prediction models; Dosing algorithm; GWAS; VKORC1; CYP2C9; Clinical Pharmacology; Klinisk farmakologi;

    Sammanfattning : Warfarin is one of the most widely used anticoagulants in the world. Treatment is complicated by a large inter-individual variation in the dose needed to reach adequate levels of anticoagulation i.e. INR 2. LÄS MER